Significant Relationship Between Brixia Score And The Degree Of Acute Respiratory Distress Syndrome In Covid 19 Patients
DOI:
https://doi.org/10.36408/mhjcm.v11i2.993Keywords:
ARDS, Brixia score, COVID 19, degree of ARAbstract
BACKGROUND: Chest X-ray has an important role in detecting early features of COVID-19. To improve risk stratification, a scoring system in chest x-ray called Brixia Score was developed. The Brixia score is designed to measure the severity of lung abnormalities in COVID-19, with an 18-point severity scale.
Deaths in COVID-19 occur mainly due to Acute Respiratory Distress Syndrome (ARDS). ARDS is classified into mild, moderate, and severe degrees. If the degree can be predicted earlier, patients can receive earlier therapy and death rate can be reduced.
AIMS: to analyze relationship between Brixia Score and degree of ARDS in COVID-19 patients.
METHOD: the research used an observational analytic method with a cross-sectional approach to 95 subjects who are positive for COVID-19 and diagnosed with ARDS, in January to December 2021. Brixia Score data was collected based on chest X-ray expertise, ARDS degree was based on medical records and blood gas analysis. Analysis of relationship between Brixia score and degree of ARDS was carried out using the Kruskal-Wallis test.
RESULT: There was a significant difference in Brixia score based on degree of ARDS (p value <0.05). The highest Brixia score was obtained in severe ARDS, while the low Brixia score was obtained in mild ARDS. This proves that there is a relationship between Brixia score and degree of ARDS.
CONCLUSION: Brixia score has a significant relationship to the degree of ARDS in COVID-19 patients.
Downloads
References
1. Bedair, Elsaid S, Ashraf S, Vincenzo N, Arun M, Muna Y, et al. Proposed Scoring System for Evaluating Clinico-radiological Severity of COVID-19 using Plain Chest X- ray changes (CO X-RADS): Preliminary results. Acta bio-medica: Atenei Parmensis. 91. 2020172. 10.23750/abm.v91i4.10664.
2. Coronavirus disease 2019 (COVID-19) Situation Report. Updated September 24, 2021; cited September 26 2021. https://wwho.int/ docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid19.pdf.
3. The Latest Development fo Coronovirus Disease (Covid-19). Updated September 17 2021; cited September 24 2021. https://covid19.kemkes.go.id/situasi-infeksi-emerging/situasi-terkini perkembangan-coronavirus-disease-covid-19-18-september-2021
4. Setiawan AH, Rachmayanti S, Kiasatina T. Conavirus Disease (COVID-19) Prenvention and Control Guide. Jakarta, Indonesia; 2020.
5. Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: The Latest Literature Review. J Penyakit Dalam Indonesia. 2020;7(1):45.
6. Burhan E, Isbaniah F, Susanto AD, Aditama TY, All E. The Diagnose and Management of COVID- 19 in Indonesia. Indonesian Pulmonologist Association. Jakarta: Indonesian Pulmonologist Association. 2020.
7. Russell A. Reeves, Corbin Pomeranz, Andrew A. Gomella, Aishwarya Gulati, Brandon Metra, Anthony Hage, et al. Performance of a Severity Score on Admission Chest Radiograph in Predicting Clinical Outcomes in Hospitalized Patients with Coronavirus Disease (COVID-19); American Journal of Roentgenology 2021 217:3
8. Luo H, Wang Y, Liu S, Chen R, Chen T, Yang Y, et al. Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19. Intern Emerg Med. 2021 Jun 30:1–11. doi: 10.1007/s11739-021-02795-9. Epub ahead of print. PMID: 34191219; PMCID: PMC8243308.
9. Aydoğan Eroğlu S, Çagavi Z, Yıldız T, Karakurt Z. COVID Interest Group. Can the usage of the chest X-ray scoring during hospitalization in patients with COVID-19 predict the severity of the dısease? Turk Thorac J. 2021; 22(3): 190-198.
10. Cozzi, D, Albanesi, M, Cavigli, E. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol med 125, 730–737 (2020). https://doi.org/10.1007/s11547-020-01232-9
11. Andrea Borghesi, Roberto Maroldi. COVID19 outbreak in Italy: experimental chest Xray scoring system for quantifying and monitoring disease progression. La radiologia medica (2020) 125:509–513. https://doi.org/10.1007/s11547-020-01200-3
12. Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distres syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-56.e1. doi:10.5694/mja2.50674
13. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distres syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. PMID: 22797452.
14. Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS?. Crit Care 24, 198 (2020). https://doi.org/10.1186/s13054-020-02911.
15. Alinejad H, Vazirinejad R, Sayadi A, Hajaliakbari Z, Pakzad Moghadam S H, Ahmadi Gohari M, et al . The Relationship Between COVID-19-induced Death and Chronic Diseases. JCCNC 2021; 7 (3) :167-174. URL: http://jccnc.iums.ac.ir/article-1-308-en.html
16. Brogna B, Bignardi E Brogna, Volpe M, Lombardi G, Rosa A, Gagliardi G, et al. A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia. Diagnostics 2021, 11, 437. https://doi.org/ 10.3390/diagnostics11030437.
17. Castillo F. Radiology in the COVID-19 pandemic: current role, recommendations for structuring the radiological report and our departments experience. Rev Chil Radiol 2020; 26(3): 88-99.
18. Jain A, Patankar S, Kale S, Bairy A. Imaging of coronavirus disease (COVID-19): a pictorial review. Pol J Radiol. 2021 Jan 10;86:e4-e18. doi: 10.5114/pjr.2021.102609. PMID: 33708269; PMCID: PMC7934747.
19. Iain Au-Yong, Yutaro Higashi, Elisabetta Giannotti, Andrew Fogarty, Joanne R. Morling, Matthew Grainge, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiological Society of North America. https://doi.org/10.1148/radiol.2021210986.
20. Fatoni, AZ, R Rakhmatullah. Acute Respiratory Distress Syndrome (ARDS) pada Pneumonia COVID-19. Journal of Anaesthesia and Pain.2021;2(1):11-24. doi: 10.21776/ub.jap.2021.002.01.02.
21. Batah SS, Fabro AT. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respir Med. 2021 Jan;176:106239. doi: 10.1016/j.rmed.2020.106239. Epub 2020 Nov 19. PMID: 33246294; PMCID: PMC7674971.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Irni Dwi Aprianty Ibrahim, Bambang Satoto, Thomas Handoyo, Antonius Gunawan Santoso, Hermina Sukmaningtyas, Farah Hendara Ningrum (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
